Exelixis is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 1 ranking category Overview

Evonik Health Care is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

Ergomed is a specialist CRO and pharmacovigilance services provider with a strong focus on rare disease, oncology, and complex clinical development programs. The company supports pharmaceutical and biotechnology sponsors through clinical trial management, regulatory support, safety services, and post-marketing pharmacovigilance.

Emmes Group is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview

Emergent BioSolutions is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 2 ranking categories Overview

Eli Lilly has become one of the most strategically important pharmaceutical companies in the world, driven by its leadership in diabetes and obesity medicines, alongside growing activity in oncology, immunology, neuroscience, and rare disease. The company’s rise reflects one of the most significant industry shifts of the current decade: the transformation of metabolic disease from a mature therapeutic area into one of the largest growth markets in global pharmaceuticals.

Eisai is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Global Pharmaceutical Companies 1 ranking category Overview

Editas Medicine is a gene editing company founded around CRISPR technology and has been active in ocular disease, hematology, and inherited disorders. Although the company has faced strategic shifts and competitive pressure, it remains a recognizable developer in the gene editing ecosystem.

Dyne Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Rare Disease & Orphan Drug Developers 1 ranking category Overview

Dynavax Technologies is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

Delpharm is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

Daiichi Sankyo is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Global Pharmaceutical Companies 1 ranking category Overview

Curia Global is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

CureVac is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

CSL is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Global Pharmaceutical Companies 1 ranking category Overview

CSL Seqirus is one of the world’s most important influenza vaccine developers and manufacturers. As part of CSL, the business benefits from biologics manufacturing expertise, global public health relationships, and strong experience in seasonal and pandemic influenza vaccine supply.

CSL Behring is one of the world’s leading specialty biologics companies, focused on plasma-derived therapies, immunoglobulins, hemophilia, hereditary angioedema, immunology, and rare diseases. Its business model is highly specialized, combining biologic manufacturing, plasma collection, global distribution, and specialist medicine.

CRISPR Therapeutics is one of the most important gene editing companies globally. Its partnership with Vertex on Casgevy established CRISPR editing as an approved therapeutic modality and marked one of the most important milestones in the history of genetic medicine.

CordenPharma is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

Corcept Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Specialty Pharma Companies 1 ranking category Overview